Rick Doblin (2019)
Description
Rick Doblin, founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), discusses the history, current research, and future potential of psychedelic-assisted therapy. In this comprehensive lecture, Doblin presents MAPS groundbreaking work with MDMA-assisted therapy for PTSD, highlighting completed and ongoing clinical trials that demonstrate remarkable efficacy rates. He also explores the regulatory pathway toward FDA approval and broader medical acceptance of psychedelic medicines. The presentation includes information about other psychedelics being researched, including psilocybin and LSD, and examines the social, political, and scientific challenges faced by the psychedelic research community. Doblin articulates a vision for the integration of psychedelics into healthcare, spiritual practice, and personal growth contexts.